|
Volumn 22, Issue 5, 2012, Pages 569-570
|
Epigenetic Therapy Leaps Ahead with Specific Targeting of EZH2
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTONE METHYLTRANSFERASE;
POLYCOMB GROUP PROTEIN;
TRANSCRIPTION FACTOR EZH2;
B LYMPHOCYTE;
CANCER THERAPY;
CELL LINE;
CELL PROLIFERATION;
CELL RENEWAL;
CYTOPLASM;
DRUG TARGETING;
EPIGENETICS;
GENE EXPRESSION;
HUMAN;
LYMPHOMA;
PRIORITY JOURNAL;
SHORT SURVEY;
SOMATIC MUTATION;
XENOGRAFT;
|
EID: 84869003466
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2012.10.016 Document Type: Short Survey |
Times cited : (25)
|
References (10)
|